261 / 510
Cuidados
Continuos
260
BIBLIOGRAFIA
Hunter W. History of aneurysm of the aorta with some remarks on aneurysm in general. Med
Obser Inq 1757;1:323-357.
Yahalom J. Superior vena cava syndrome. En de Vita VT, Lawrence TS, Rosemberg SA. Cancer.
Principles and Practice of Oncology.2011, 9 edición. Pag.2123-2129
Wilson LD, Detterbeck FC, Yahalom J. Superior vena cava syndrome with malignant causes. N
Engl J Med 2007; 356:1862
Lepper PM, Ott SR, Hoppe H et al. Superior vena cava syndrome in thoracic malignancies.
Respir Care 2011; 56(5):653-666.
Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics
and evolving etiology. Medicine (Baltimore). 2006; 85(1):37.
Perez-Soler R, McLaughlin P, Velasquez WS, Hagemeister FB, Zornoza J, Manning JT, et al.
Clinical features and results of management of superior vena cava syndrome secondary to
lymphoma. J Clin Oncol 1984;2(4):260-266.
Otten TR, Stein PD, Patel KC, Mustafa S, Silbergleit A. Thromboembolic disease involving the
superior vena cava and brachiocephalic veins. Chest 2003;123(3):809-812
Lavernia G, Romero I. Complicaciones respiratorias. En Manual SEOM de cuidados continuos.
pag.218-220
Kim HJ, Kim HS, Chung SH. CT diagnosis of superior vena cava syndrome: importante of
collateral vessels. AJR Am J Roentgenol. 1993;161(3):539.
Yu JB, Wilson LD, Detterbeck FC. Superior vena cava syndrome-a proposed classification
system and algorithm for management. J Thorac Oncol 2008; 3:811.
Fagedet D, Thony F, Timsit JF et al. Endovascular treatment of malignat superior vena cava
síndrome: Results and predictive factors of clinical efficacy. Cardiovasc Intervent Radiol, 2013;
36:140-149
Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena
caval obstruction in carcinoma of the bronchus: a systematic review. Clin Oncol (R Coll Radiol)
2002;14: 338-51.
13.Rodriguez Sanchez C. Manual de Urgencias en Oncología. SEOM 2007.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.